Cheminformatic Tools and Databases for Pharmacology

session 94573 - Total of 2 hits - Display   hits per page:

Add another drug(s) by one keyword:
Exemple: “nib“ and click on the Search button (do not press Enter on the keyboard)

1 INNClassRoute (list)PK parameters= Cmax; Tmax; F: bioavailability; t1/2: half-life; VD: volume of distribution; Cl: clearance; PPB: plasma protein binding;(EQN means that value was calculated using VD=(Cl*t1/2)/0.693)Primary Target and PDB code of Protein-Drug complexTargets from DrugCentral Links
M TRIHEPTANOIN (is an active metabolite)

TRIHEPTANOIN


ATC A16AX17

METABOLISM
MEDIUM-CHAIN TRIGLYCERIDE
TREATMENT OF LONG-CHAIN FATTY ACID OXIDATION DISORDERS (LC-FAOD)

-

Cmax 319.9 MICROMOLAR

Tmax 1.2 HOUR

PPB 80 PERCENT

Cl 280.1 LITER / HOUR (65 KILOGRAM)

Unknown - more at DrugCentralEMA

ANSM (in French)

Inxight Drugs
Dailymed
Drugs.com

SIDER side effects

Chemical Probes Portal

ChEMBL
BindingDB
DrugBank

2 INNClassRoute (list)PK parameters= Cmax; Tmax; F: bioavailability; t1/2: half-life; VD: volume of distribution; Cl: clearance; PPB: plasma protein binding;(EQN means that value was calculated using VD=(Cl*t1/2)/0.693)Primary Target and PDB code of Protein-Drug complexTargets from DrugCentral Links
TRIHEPTANOIN (has an active metabolite)

TRIHEPTANOIN


ATC A16AX17

METABOLISM
MEDIUM-CHAIN TRIGLYCERIDE
TREATMENT OF LONG-CHAIN FATTY ACID OXIDATION DISORDERS (LC-FAOD)
LONG-CHAIN FAOD ENZYME DEFICIENCIES
EXTENSIVELY HYDROLYZED TO HEPTANOATE AND GLYCEROL BY PANCREATIC LIPASES

ORAL

Unknown - more at DrugCentralEMA

ANSM (in French)

Inxight Drugs
Dailymed
Drugs.com

SIDER side effects

Chemical Probes Portal

ChEMBL
BindingDB
DrugBank



Copyright © 2019 Université Côte d'Azur CNRS - All rights reserved
  | Contact |